Real-World Outcomes in Patients with Transformed Follicular Lymphoma Treated with CD19-Targeting CAR-T Therapy

被引：0

作者：

Rivas-Delgado, Alfredo ^{[1
]}

Luttwak, Efrat ^{[1
]}

Drill, Esther ^{[2
]}

Goldstein, Ilan ^{[3
]}

Landego, Ivan ^{[3
,4
]}

Tomas, Ana Alarcon ^{[3
]}

Parascondola, Allison ^{[3
]}

Saldia, Amethyst ^{[3
]}

Caron, Philip ^{[1
]}

Dahi, Parastoo B. ^{[3
,4
]}

Epstein-Peterson, Zachary D. ^{[1
]}

Falchi, Lorenzo ^{[1
]}

Hamlin, Paul A. ^{[1
]}

Johnson, William ^{[1
,4
]}

Kumar, Anita ^{[5
]}

Lin, Richard J. ^{[3
,4
]}

Lue, Jennifer Kimberly ^{[1
]}

Owens, Colette ^{[1
]}

Noy, Ariela ^{[1
]}

Scordo, Michael ^{[3
,4
]}

Dogan, Ahmet ^{[6
]}

Seshan, Venkatraman ^{[2
]}

Zelenetz, Andrew D. ^{[1
]}

Perales, Miguel-Angel ^{[3
,4
]}

Shouval, Roni ^{[3
,4
]}

Palomba, Maria Lia ^{[1
,4
]}

Shah, Gunjan L. ^{[3
,4
]}

Salles, Gilles ^{[1
,4
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, Barcelona, Spain

[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA

[3] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA

[5] Mem Sloan Kettering Canc Ctr, New York, NY USA

[6] Mem Sloan Kettering Canc Ctr, Hematopathol Serv, Dept Pathol & Lab Med, New York, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-187379

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[31] Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real-World Setting
Bennedsen, Tine Litske
Simonsen, Mikkel Runason
Jensen, Paw
Brown, Peter
Josefsson, Paer
Khurana, Arushi
Maurer, Matthew
Clausen, Michael Roost
Dessau-Arp, Andriette
Jorgensen, Jennifer Bogh
Jorgensen, Judit
Larsen, Thomas Stauffer
Pedersen, Lars Moller
Jakobsen, Lasse Hjort
El-Galaly, Tarec Christoffer
EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
[32] Beyond CD19 CAR-T cells in lymphoma
Leung, Wingchi K.
Ayanambakkam, Adanma
Heslop, Helen E.
Hill, LaQuisa C.
CURRENT OPINION IN IMMUNOLOGY, 2022, 74 : 46 - 52
[33] Risk Factors for CD19-Targeting CAR T Manufacturing Failure and Patient Outcomes: A Report from the UK National CAR T Panel
Dulobdas, Vaishali
Kirkwood, Amy A.
Serpenti, Fabio
Gautama, Brijesh
Panapoulou, Aikaterini
Gabriel, Sumantha
Malladi, Ram
Pealing, Jessica
Bonney, Denise
Nicholson, Emma
Besley, Caroline
Ghorashian, Sara
Davies, Elizabeth
Chappell, Jackie
Black, Anne
Menne, Tobias
O'Reilly, Maeve
Sanderson, Robin
Chaganti, Sridhar
BLOOD, 2023, 142
[34] OUTCOMES OF CAR-T CELL THERAPY FOR LARGE B CELL LYMPHOMA IN PATIENTS OF 70 YEARS AND OLDER: MULTICENTRIC REAL WORLD EXPERIENCE
Bailen, Rebeca
Kwon, Mi
Iacoboni, Gloria
Luis Reguera, Juan
Lopez-Corral, Lucia
Hernani, Rafael
Ortiz-Maldonado, Valentin
Guerreiro, Manuel
Carolina Caballero, Ana
Guerra Dominguez, Maria Luisa
Sanchez Pina, Jose Maria
Mmussetti, Alberto
Manuel Sancho, Juan
Bastos-Oreiro, Mariana
Catala, Eva
Delgado, Javier
Luzardo Henriquez, Hugo
Sanz, Jaime
Calbacho Robles, Maria
Carpio, Cecilia
Maria Ribera, Jose
Sureda, Anna
Briones, Javier
Carlos Hernandez-Boluda, Juan
Martinez-Cibrian, Nuria
Luis Diez-Martin, Jose
Martin, Alejandro
Barba, Pere
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 204 - 204
[35] CAR-T Therapy in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: Real World Outcomes Based on Tumor Biology
Brinkman, Luke
Wagner, Charlotte B.
Ying, Jian
Fraga, Martina
Marini, Bernard L.
Scappaticci, Gianni Bruno
Ptachcinski, Jonathan
Patel, Sagar S.
BLOOD, 2022, 140 : 9546 - 9547
[36] Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study
Farina, Mirko
Bernardi, Simona
Malagola, Michele
Re, Alessandro
Galli, Eugenio
Riva, Marcello
Cutini, Ilaria
Leoni, Alessandro
Martino, Massimo
Ferrari, Silvia
Battipaglia, Giorgia
Novo, Mattia
Musso, Maurizio
Grillo, Giovanni
Santarone, Stella
Krampera, Mauro
Aroldi, Andrea
Polverelli, Nicola
Arcaini, Luca
Xhahysa, Besjana
Avenoso, Daniele
Tisi, Maria Chiara
Chiusolo, Patrizia
Russo, Domenico
BONE MARROW TRANSPLANTATION, 2025,
[37] Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel
Gajra, Ajeet
Zettler, Marjorie E.
Phillips, Eli G., Jr.
Klink, Andrew J.
Kish, Jonathan K.
Mehta, Sonam
Feinberg, Bruce
BLOOD, 2019, 134
[38] Real-world outcome of myeloma patients qualifying for CAR-T treatment in the pre-CAR-T era
Brechbuhl, S.
Bacher, U.
Jeker, B.
Pabst, T.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 100 - 101
[39] Real-world outcome of myeloma patients qualifying for CAR-T treatment in the pre-CAR-T era
Brechbuhl, S.
Bacher, U.
Jeker, B.
Pabst, T.
SWISS MEDICAL WEEKLY, 2020, : 17S - 17S
[40] Autologous CD19-Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis
Nicolai, Rebecca
Merli, Pietro
Alvarez, Patricia Moran
Bracaglia, Claudia
Del Bufalo, Francesca
Marasco, Emiliano
Caiello, Ivan
Prencipe, Giusi
Algeri, Mattia
Cefalo, Maria G.
Becilli, Marco
Quintarelli, Concetta
Sinibaldi, Matilde
Hanssens, Linda
De Benedetti, Fabrizio
Locatelli, Franco
ARTHRITIS & RHEUMATOLOGY, 2024, 76 (10) : 1560 - 1565

← 1 2 3 4 5 →